These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16923419)

  • 1. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study.
    Schulze F; Lenzen H; Hanefeld C; Bartling A; Osterziel KJ; Goudeva L; Schmidt-Lucke C; Kusus M; Maas R; Schwedhelm E; Strödter D; Simon BC; Mügge A; Daniel WG; Tillmanns H; Maisch B; Streichert T; Böger RH
    Am Heart J; 2006 Sep; 152(3):493.e1-8. PubMed ID: 16923419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma asymmetric dimethylarginine and cystatin C levels in patients with coronary artery disease].
    YOU L; ZHAO CX; SHAO JM; ZHANG L; WANG DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):798-800. PubMed ID: 21092647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction.
    Maas R; Wenske S; Zabel M; Ventura R; Schwedhelm E; Steenpass A; Klemm H; Noldus J; Böger RH
    Eur Urol; 2005 Dec; 48(6):1004-11; discussion 1011-2. PubMed ID: 16139418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X.
    Okyay K; Cengel A; Sahinarslan A; Tavil Y; Turkoglu S; Biberoglu G; Hasanoglu A
    Coron Artery Dis; 2007 Nov; 18(7):539-44. PubMed ID: 17925607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethylarginine and coronary collateral vessel development.
    Kocaman SA; Sahinarslan A; Biberoglu G; Hasanoglu A; Akyel A; Timurkaynak T; Cengel A
    Coron Artery Dis; 2008 Nov; 19(7):469-74. PubMed ID: 18923242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography.
    Lu TM; Chung MY; Lin MW; Hsu CP; Lin SJ
    Int J Cardiol; 2011 Dec; 153(2):135-40. PubMed ID: 21794936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects.
    Schulze F; Maas R; Freese R; Schwedhelm E; Silberhorn E; Böger RH
    Eur J Clin Invest; 2005 Oct; 35(10):622-6. PubMed ID: 16178881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethyl-arginine and coronary artery calcification in young adults entering middle age: the CARDIA Study.
    Iribarren C; Husson G; Sydow K; Wang BY; Sidney S; Cooke JP
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):222-9. PubMed ID: 17446800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
    Maas R; Dentz L; Schwedhelm E; Thoms W; Kuss O; Hiltmeyer N; Haddad M; Klöss T; Standl T; Böger RH
    Crit Care Med; 2007 Aug; 35(8):1876-81. PubMed ID: 17581491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of plasma asymmetric dimethylarginine (ADMA) level and L-arginine/ADMA ratio on the development of coronary collaterals].
    Selçuk MT; Selçuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Duru E; Saşmaz A
    Turk Kardiyol Dern Ars; 2008 Apr; 36(3):150-5. PubMed ID: 18626206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stent placement in patients with coronary heart disease decreases plasma levels of the endogenous nitric oxide synthase inhibitor ADMA.
    Ajtay Z; Scalera F; Cziráki A; Horváth I; Papp L; Sulyok E; Szabo C; Martens-Lobenhoffer J; Awiszus F; Bode-Böger SM
    Int J Mol Med; 2009 May; 23(5):651-7. PubMed ID: 19360324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension.
    Curgunlu A; Uzun H; Bavunoğlu I; Karter Y; Genç H; Vehid S
    J Hum Hypertens; 2005 Aug; 19(8):629-33. PubMed ID: 15829997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients.
    Zoccali C; Mallamaci F; Maas R; Benedetto FA; Tripepi G; Malatino LS; Cataliotti A; Bellanuova I; Böger R;
    Kidney Int; 2002 Jul; 62(1):339-45. PubMed ID: 12081596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
    Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations.
    Altinova AE; Arslan M; Sepici-Dincel A; Akturk M; Altan N; Toruner FB
    J Clin Endocrinol Metab; 2007 May; 92(5):1881-5. PubMed ID: 17311854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
    Schnabel R; Blankenberg S; Lubos E; Lackner KJ; Rupprecht HJ; Espinola-Klein C; Jachmann N; Post F; Peetz D; Bickel C; Cambien F; Tiret L; Münzel T
    Circ Res; 2005 Sep; 97(5):e53-9. PubMed ID: 16100045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data.
    Maas R; Schulze F; Baumert J; Löwel H; Hamraz K; Schwedhelm E; Koenig W; Böger RH
    Clin Chem; 2007 Apr; 53(4):693-701. PubMed ID: 17317881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Dietary Approaches to Stop Hypertension score and Alternative Healthy Eating Index score with plasma asymmetrical dimethylarginine levels in patients referring for coronary angiography.
    Mokhtari Z; Hosseini S; Miri R; Baghestani AR; Zahedirad M; Rismanchi M; Nasrollahzadeh J
    J Hum Nutr Diet; 2015 Aug; 28(4):350-6. PubMed ID: 25786774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of serum asymmetric dimethylarginine levels for the determination of masked hypertension in patients with diabetes mellitus.
    Taner A; Unlu A; Kayrak M; Tekinalp M; Ayhan SS; Arıbaş A; Erdem SS
    Atherosclerosis; 2013 Jun; 228(2):432-7. PubMed ID: 23540293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.